Literature DB >> 27415407

Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.

L Shi1, B D Webb1, A H Birch1, L Elkhoury1, J McCarthy1, X Cai1, K Oishi1, L Mehta1, G A Diaz1, L Edelmann1, R Kornreich1.   

Abstract

The Ashkenazi Jewish (AJ) population has an increased risk for a variety of recessive diseases due to historical founder effects and genetic drift. For some, the disease-causing founder mutations have been identified and well-characterized, but for others, further study is necessary. The purpose of this study is to assess the carrier frequencies of 85 pathogenic variants causative of 29 recessive conditions in the AJ population. Up to 3000 AJ individuals were genotyped by Luminex MagPlex® -TAG™ bead array or Agena Bioscience™ MassARRAY assays. We identified seven conditions with carrier frequencies higher than 1 in 100, nine between 1 in 100 and 1 in 200, and four between 1 in 200 and 1 in 500. Variants in nine conditions had a detected carrier rate of less than 1 in 500 or were not identified in approximately 2000 AJ individuals. We assessed the combined AJ carrier frequency for 18 relatively prevalent diseases to be 1 in 6, and the risk of AJ individuals to be a carrier couple for one of these 18 diseases as 1 in 441. We note additional recessive genetic conditions should be considered for AJ carrier screening panels.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ashkenazi Jewish; founder mutation; genetic counseling; prenatal carrier screening

Mesh:

Year:  2016        PMID: 27415407      PMCID: PMC5237408          DOI: 10.1111/cge.12834

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

1.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).

Authors:  E Schollen; S Kjaergaard; E Legius; M Schwartz; G Matthijs
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

2.  Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.

Authors:  B A Bejjani; D W Stockton; R A Lewis; K F Tomey; D K Dueker; M Jabak; W F Astle; J R Lupski
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

3.  Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.

Authors:  AbdulRazaq A H Sokoro; Joyce Lepage; Nick Antonishyn; Ryan McDonald; Cheryl Rockman-Greenberg; James Irvine; Denis C Lehotay
Journal:  J Inherit Metab Dis       Date:  2010-06-24       Impact factor: 4.982

4.  Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene.

Authors:  Edwin M Stone; Xunda Luo; Elise Héon; Byron L Lam; Richard G Weleber; Jennifer A Halder; Louisa M Affatigato; Jacqueline B Goldberg; Alexander Sumaroka; Sharon B Schwartz; Artur V Cideciyan; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-28       Impact factor: 4.799

5.  An Ashkenazi founder mutation in the PKHD1 gene.

Authors:  Adina Quint; Michal Sagi; Shai Carmi; Hagit Daum; Michal Macarov; Ziva Ben Neriah; Vardiela Meiner; Orly Elpeleg; Israela Lerer
Journal:  Eur J Med Genet       Date:  2015-12-23       Impact factor: 2.708

6.  Smith-Lemli-Opitz (RHS) syndrome: holoprosencephaly and homozygous IVS8-1G-->C genotype.

Authors:  M J Nowaczyk; S A Farrell; W L Sirkin; L Velsher; P A Krakowiak; J S Waye; F D Porter
Journal:  Am J Med Genet       Date:  2001-09-15

7.  Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith--Lemli--Opitz syndrome.

Authors:  P E Jira; R J Wanders; J A Smeitink; J De Jong; R A Wevers; W Oostheim; J H Tuerlings; R C Hennekam; R C Sengers; H R Waterham
Journal:  Ann Hum Genet       Date:  2001-05       Impact factor: 1.670

8.  Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.

Authors:  E Schollen; S Kjaergaard; T Martinsson; S Vuillaumier-Barrot; M Dunoe; L Keldermans; N Seta; G Matthijs
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

9.  ACMG position statement on prenatal/preconception expanded carrier screening.

Authors:  Wayne W Grody; Barry H Thompson; Anthony R Gregg; Lora H Bean; Kristin G Monaghan; Adele Schneider; Roger V Lebo
Journal:  Genet Med       Date:  2013-04-25       Impact factor: 8.822

10.  Carrier screening in individuals of Ashkenazi Jewish descent.

Authors:  Susan J Gross; Beth A Pletcher; Kristin G Monaghan
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

View more
  5 in total

Review 1.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

2.  Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.

Authors:  Cristina Fortuno; Kristy Lee; Magali Olivier; Tina Pesaran; Phuong L Mai; Kelvin C de Andrade; Laura D Attardi; Stephanie Crowley; D Gareth Evans; Bing-Jian Feng; Ann K M Foreman; Megan N Frone; Robert Huether; Paul A James; Kelly McGoldrick; Jessica Mester; Bryce A Seifert; Thomas P Slavin; Leora Witkowski; Liying Zhang; Sharon E Plon; Amanda B Spurdle; Sharon A Savage
Journal:  Hum Mutat       Date:  2020-12-25       Impact factor: 4.700

3.  Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review.

Authors:  Jeffrey M Boertien; Pedro A B Pereira; Velma T E Aho; Filip Scheperjans
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

4.  Rare deleterious germline variants and risk of lung cancer.

Authors:  Yanhong Liu; Jun Xia; James McKay; Spiridon Tsavachidis; Xiangjun Xiao; Margaret R Spitz; Chao Cheng; Jinyoung Byun; Wei Hong; Yafang Li; Dakai Zhu; Zhuoyi Song; Susan M Rosenberg; Michael E Scheurer; Farrah Kheradmand; Claudio W Pikielny; Christine M Lusk; Ann G Schwartz; Ignacio I Wistuba; Michael H Cho; Edwin K Silverman; Joan Bailey-Wilson; Susan M Pinney; Marshall Anderson; Elena Kupert; Colette Gaba; Diptasri Mandal; Ming You; Mariza de Andrade; Ping Yang; Triantafillos Liloglou; Michael P A Davies; Jolanta Lissowska; Beata Swiatkowska; David Zaridze; Anush Mukeria; Vladimir Janout; Ivana Holcatova; Dana Mates; Jelena Stojsic; Ghislaine Scelo; Paul Brennan; Geoffrey Liu; John K Field; Rayjean J Hung; David C Christiani; Christopher I Amos
Journal:  NPJ Precis Oncol       Date:  2021-02-16

5.  Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.

Authors:  Gidon Akler; Ashley H Birch; Nicole Schreiber-Agus; Xiaoqiang Cai; Guiqing Cai; Lisong Shi; Chunli Yu; Anastasia M Larmore; Geetu Mendiratta-Vij; Lama Elkhoury; Mitchell W Dillon; Jun Zhu; Andrew S Mclellan; Funda E Suer; Bryn D Webb; Eric E Schadt; Ruth Kornreich; Lisa Edelmann
Journal:  Mol Genet Genomic Med       Date:  2019-12-27       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.